CDTVSHALO• 3 Months (Normalized)
CDT vs HALO (CDT Equity Inc. vs Halozyme Therapeutics Inc.)
Showing Closing Date Range from Jul 8 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CDT Performance $0.93
-99.16%
CDT Equity Inc.
Normalized Baseline0.00%
HALO Performance $109.72
+36.52%
Halozyme Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin HALO LEADS
-135.68 pts
HALO outperforming by 135.68 percentage points
CDTHALO
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CDT HALO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(64 dates)
| Date | CDT Price | CDT Gain (%) | HALO Price | HALO Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $0.93 | -99.16% | $109.72 | +36.52% | -135.68% |
| Oct 05, 2026 | $0.92 | -99.17% | $108.31 | +34.76% | -133.93% |
| Oct 02, 2026 | $0.99 | -99.10% | $109.86 | +36.69% | -135.79% |
| Oct 01, 2026 | $1.25 | -98.87% | $106.94 | +33.06% | -131.93% |
| Sep 30, 2026 | $1.36 | -98.77% | $110.40 | +37.36% | -136.13% |
| Sep 29, 2026 | $1.45 | -98.69% | $111.56 | +38.81% | -137.50% |
| Sep 28, 2026 | $1.90 | -98.28% | $112.89 | +40.46% | -138.74% |
| Sep 25, 2026 | $2.00 | -98.19% | $113.90 | +41.72% | -139.91% |
| Sep 24, 2026 | $3.03 | -97.26% | $- | - | |
| Sep 23, 2026 | $3.38 | -96.95% | $112.44 | +39.90% | -136.85% |
| Sep 22, 2026 | $3.55 | -96.79% | $115.13 | +43.25% | -140.04% |
| Sep 21, 2026 | $3.85 | -96.52% | $111.45 | +38.67% | -135.19% |
| Sep 18, 2026 | $4.35 | -96.06% | $112.45 | +39.92% | -135.98% |
| Sep 17, 2026 | $4.75 | -95.70% | $109.68 | +36.47% | -132.17% |
| Sep 16, 2026 | $4.95 | -95.52% | $108.44 | +34.93% | -130.45% |
Page 1 of 5